🇺🇸 FDA
Patent

US 8961975

Monoclonal antibodies that neutralize anthrax toxins

granted A61KA61K2039/505A61K51/1009

Quick answer

US patent 8961975 (Monoclonal antibodies that neutralize anthrax toxins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K51/1009, A61P, A61P31/04